Capital Research Global Investors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350M Sell
1,669,556
-2,739,416
-62% -$688M 0.05% 198
2025
Q4
$1.25B Sell
4,408,972
-140,097
-3% -$43.8M 0.23% 92
2025
Q3
$1.4B Sell
4,549,069
-187,058
-4% -$58.6M 0.26% 90
2025
Q2
$1.49B Sell
4,736,127
-1,340,413
-22% -$387M 0.3% 75
2025
Q1
$1.6B Sell
6,076,540
-1,369,765
-18% -$371M 0.35% 69
2024
Q4
$1.94B Sell
7,446,305
-326,099
-4% -$82.1M 0.4% 60
2024
Q3
$1.81B Buy
7,772,404
+621,381
+9% +$128M 0.38% 65
2024
Q2
$1.44B Sell
7,151,023
-411,070
-5% -$74.1M 0.32% 71
2024
Q1
$1.3B Sell
7,562,093
-1,914,530
-20% -$357M 0.29% 77
2023
Q4
$2.06B Buy
9,476,623
+1,556,455
+20% +$267M 0.51% 52
2023
Q3
$1.26B Buy
7,920,168
+2,748,828
+53% +$616M 0.35% 73
2023
Q2
$1.49B Sell
5,171,340
-390,886
-7% -$119M 0.4% 67
2023
Q1
$1.77B Sell
5,562,226
-589,135
-10% -$175M 0.51% 58
2022
Q4
$1.81B Sell
6,151,361
-304,124
-5% -$83.9M 0.55% 52
2022
Q3
$1.48B Sell
6,455,485
-287,549
-4% -$72M 0.49% 58
2022
Q2
$1.47B Sell
6,743,034
-186,598
-3% -$42.4M 0.46% 64
2022
Q1
$1.85B Sell
6,929,632
-881,880
-11% -$216M 0.46% 57
2021
Q4
$2.08B Buy
7,811,512
+579,764
+8% +$168M 0.46% 51
2021
Q3
$2.06B Buy
7,231,748
+343,978
+5% +$98.1M 0.48% 49
2021
Q2
$1.89B Buy
6,887,770
+1,220,372
+22% +$332M 0.44% 55
2021
Q1
$1.48B Buy
5,667,398
+23,058
+0.4% +$6.18M 0.36% 68
2020
Q4
$1.44B Sell
5,644,340
-164,720
-3% -$40.9M 0.37% 66
2020
Q3
$1.37B Sell
5,809,060
-15,868
-0.3% -$3.34M 0.41% 55
2020
Q2
$1.13B Sell
5,824,928
-1,091,074
-16% -$209M 0.36% 64
2020
Q1
$1.15B Buy
6,916,002
+231,911
+3% +$42.4M 0.45% 59
2019
Q4
$1.14B Sell
6,684,091
-348,276
-5% -$58M 0.34% 69
2019
Q3
$1.16B Buy
7,032,367
+1,772,336
+34% +$249M 0.38% 69
2019
Q2
$628M Sell
5,260,031
-8,411
-0.2% -$862K 0.2% 114
2019
Q1
$501M Buy
5,268,442
+977,623
+23% +$83.8M 0.16% 130
2018
Q4
$340M Buy
4,290,819
+102,005
+2% +$8.63M 0.12% 159
2018
Q3
$444M Sell
4,188,814
-413,919
-9% -$38.8M 0.13% 147
2018
Q2
$394M Sell
4,602,733
-561,222
-11% -$50.3M 0.11% 158
2018
Q1
$448M Sell
5,163,955
-529,945
-9% -$41.2M 0.13% 153
2017
Q4
$393M Sell
5,693,900
-327,733
-5% -$21.5M 0.12% 155
2017
Q3
$332M Buy
6,021,633
+138,000
+2% +$7.54M 0.1% 171
2017
Q2
$302M Buy
5,883,633
+145,724
+3% +$6.33M 0.09% 180
2017
Q1
$247M Buy
5,737,909
+326,276
+6% +$14M 0.08% 204
2016
Q4
$204M Buy
5,411,633
+236,600
+5% +$8.81M 0.07% 225
2016
Q3
$212M Buy
5,175,033
+37,000
+0.7% +$1.46M 0.07% 213
2016
Q2
$155M Sell
5,138,033
-1,185,000
-19% -$36.9M 0.05% 245
2016
Q1
$210M Buy
6,323,033
+313,600
+5% +$9.85M 0.07% 217
2015
Q4
$227M Buy
6,009,433
+1,805,000
+43% +$60.8M 0.08% 207
2015
Q3
$109M Buy
4,204,433
+460,000
+12% +$14M 0.04% 279
2015
Q2
$116M Buy
3,744,433
+1,291,700
+53% +$38.1M 0.04% 289
2015
Q1
$81.8M Hold
2,452,733
0.03% 318
2014
Q4
$113M Sell
2,452,733
-675,345
-22% -$28.9M 0.04% 293
2014
Q3
$115M Buy
3,128,078
+57,678
+2% +$2.11M 0.04% 284
2014
Q2
$122M Hold
3,070,400
0.04% 273
2014
Q1
$146M Sell
3,070,400
-168,566
-5% -$7.46M 0.05% 248
2013
Q4
$120M Sell
3,238,966
-30,110
-0.9% -$1.11M 0.04% 265
2013
Q3
$118M Hold
3,269,076
0.05% 260
2013
Q2
$103M Buy
+3,269,076
New +$92.6M 0.04% 260

Other funds holding PODD

Capital Research Global Investors's PODD Position: Q1 2026 in Review

Capital Research Global Investors reduced its Insulet (PODD) stake by 62% in Q1 2026, selling an estimated $688M and leaving 1,669,556 shares worth $350M. The position accounts for 0.05% of the portfolio, ranked #198.

Capital Research Global Investors first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08B in Q4 2021. 786 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Capital Research Global Investors held 1,669,556 shares of Insulet worth $350M as of Q1 2026.
  • Capital Research Global Investors sold 2,739,416 Insulet shares in Q1 2026, an estimated $688M.
  • Insulet made up 0.05% of Capital Research Global Investors's portfolio in Q1 2026, its #198 holding.
  • Capital Research Global Investors first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Capital Research Global Investors's Insulet position peaked at $2.08B in Q4 2021.
  • 786 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.